{ 'indexed': { 'date-parts': [[2021, 12, 19]],
'date-time': '2021-12-19T11:20:43Z',
'timestamp': 1639912843185},
'reference-count': 0,
'publisher': 'Bentham Science Publishers Ltd.',
'content-domain': {'domain': [], 'crossmark-restriction': False},
'short-container-title': ['CHDDT'],
'published-print': {'date-parts': [[2021, 12, 14]]},
'abstract': '<jats:sec>\n'
'<jats:title>Aims:</jats:title>\n'
'<jats:p> The study aimed to assess the inhibitory effect of Vitamin C on '
'angiotensin-converting enzyme 2.\n'
'</jats:p>\n'
'</jats:sec>\n'
'<jats:sec>\n'
'<jats:title>Background:</jats:title>\n'
'<jats:p>Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory '
'syndrome coronavirus 2 (SARS-CoV-2), which uses angiotensin-converting enzyme 2 (ACE-II)\n'
'as the first route to infect human cells. Accordingly, agents with potential inhibition of '
'ACE-II receptors might be effective in the prevention and management of COVID-19.</jats:p>\n'
'</jats:sec>\n'
'<jats:sec>\n'
'<jats:title>Objective:</jats:title>\n'
'<jats:p>The goal of this work was to assess the possible inhibitory effect of ACE-II on '
'ascorbic\n'
'acid using an ex vivo approach based on the inhibition of diminazene-induced '
'vasorelaxation.</jats:p>\n'
'</jats:sec>\n'
'<jats:sec>\n'
'<jats:title>Material and Methods:</jats:title>\n'
'<jats:p>In the present study, diminazene was used as a known specific inhibitor of\n'
'ACE-II. Then, the vasorelaxant effect of ascorbic acid on diminazene-induced relaxation was '
'examined using isolated aortic rings. All experiments of this study were evaluated on '
'isolated aortic\n'
'rings precontracted by epinephrine.</jats:p>\n'
'</jats:sec>\n'
'<jats:sec>\n'
'<jats:title>Results:</jats:title>\n'
'<jats:p>The results confirmed that diminazene-induced vasorelaxation in a dose-dependent '
'manner. More interestingly, ascorbic acid inhibited diminazene-induced vasorelaxation in a '
'dose-dependent manner.\n'
'</jats:p>\n'
'</jats:sec>\n'
'<jats:sec>\n'
'<jats:title>Conclusion:</jats:title>\n'
'<jats:p> This investigation provides valuable experimental proof of the efficacy of ascorbic\n'
'acid (Vitamin C) on inhibiting ex vivo vascular angiotensin-converting enzyme II, which is '
'known\n'
'among the pharmacological targets of anti-Covid-19 drugs.</jats:p>\n'
'</jats:sec>',
'DOI': '10.2174/1871529x21666211214153308',
'type': 'journal-article',
'created': { 'date-parts': [[2021, 12, 15]],
'date-time': '2021-12-15T06:28:11Z',
'timestamp': 1639549691000},
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': ['Vitamin C inhibits Angiotensin-Converting Enzyme-2 in Isolated Rat Aortic Ring'],
'prefix': '10.2174',
'volume': '21',
'author': [ { 'given': 'Ayoub',
'family': 'Amssayef',
'sequence': 'first',
'affiliation': [ { 'name': 'Department of Biology, Team of Ethnopharmacology and '
'Pharmacognosy, Faculty of Sciences and Techniques, Errachidia, '
'Moulay Ismail, University of Meknes, BP 509, Boutalamine, 52000 '
'Errachidia, Morocco'}]},
{ 'given': 'Ismail',
'family': 'Bouadid',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Biology, Team of Ethnopharmacology and '
'Pharmacognosy, Faculty of Sciences and Techniques, Errachidia, '
'Moulay Ismail, University of Meknes, BP 509, Boutalamine, 52000 '
'Errachidia, Morocco'}]},
{ 'given': 'Mohamed',
'family': 'Eddouks',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Biology, Team of Ethnopharmacology and '
'Pharmacognosy, Faculty of Sciences and Techniques, Errachidia, '
'Moulay Ismail, University of Meknes, BP 509, Boutalamine, 52000 '
'Errachidia, Morocco'}]}],
'member': '965',
'container-title': ['Cardiovascular & Hematological Disorders-Drug Targets'],
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'http://eurekaselect.com/article/download/198905',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://www.eurekaselect.com/198905/article',
'content-type': 'text/html',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'http://eurekaselect.com/article/download/198905',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2021, 12, 15]],
'date-time': '2021-12-15T06:28:15Z',
'timestamp': 1639549695000},
'score': 1,
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 12, 14]]},
'references-count': 0,
'alternative-id': ['LiveAll1'],
'URL': 'http://dx.doi.org/10.2174/1871529x21666211214153308',
'relation': {},
'ISSN': ['1871-529X'],
'issn-type': [{'value': '1871-529X', 'type': 'print'}],
'subject': [ 'Cardiology and Cardiovascular Medicine', 'Pharmacology', 'Hematology', 'Molecular Medicine',
'General Medicine'],
'published': {'date-parts': [[2021, 12, 14]]}}
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.